院内小儿感冒舒颗粒治疗小儿急性上呼吸道感染观察

摘要

Objective In order to further prove that using Pediatric Ganmaoshu Particles to cure children’s upper respiratory tract infection has ideal effect, dialectical its pharmacological ingredients and drug treatment of practical significance. Methods According to our hospital from August 2012 to August 2013, the receiving and giving treatment of children with upper respiratory tract infection, 1120 people, all patients were randomly divided into two groups:treatment group A and group B, the treatment group A selected Ganmaoshu Particles, the treatment group B choose regular children cold potions, treatment time was 1 week, compared with two groups of children. Results Treatment group A cured 196 people, 307 people was effective, 57 people was invalid, the cure rate was 35%, total effective rate was 89.82%, medication without efficiency was 10.18%;Treatment group B 103 were cured, 321 people was effective, 136 people was invalid, the cure rate was 18.39%, total effective rate was 75.71%, no efficiency was 24.29%. In addition, average treatment time of treatment group A were was (2.5+1.5)d, treatment group B was (5.3+2.1)d. Patients of two groups has significant statistical differences in the treatment results, P<0.05. In addition, during the period of treatment, two groups of patients did not appear bad recession or kidney, lung, heart and other organs, efficacy was stable. Conclusion Pediatric Ganmaoshu Particles is made of a proprietary Chinese medicine preparations, the hospital routine treatment has ideal practical application value, its pharmacological moderate performance, relatively stable efficacy, fast treatment effect, little drug adverse reaction and side effect, can be used as a clinical routine in children with acute upper respiratory tract infection drug use.%目的：为了进一步证明使用小儿感冒舒颗粒治疗儿童上呼吸道感染有理想的治疗效果,辩证其药理成分与药物作用具有实际的治疗意义。方法根据本院自2012年8月~2013年8月间所接收并给予治疗的儿童上呼吸道感染患者1120人,将所有患者随机、平均分为两组,治疗组A和治疗组B,治疗组A选用小儿感冒舒颗粒,治疗组B选用常规儿童感冒药剂,治疗时间为1周,对比两组患儿的治疗情况。结果治疗组A中196人治愈,307人用药有效,57人用药无效,治愈率为35%,用药总有效率为89.82%,用药无效率为10.18%；治疗组B中103人治愈,321人用药有效,136人用药无效,治愈率为18.39%,总有效率为75.71%,无效率为24.29%。另外治疗组A患者平均治疗时间为(2.5±1.5)d,治疗组B平均治疗时间为(5.3±2.1)d。两组患者的治疗结果对比差异有统计学意义, P均<0.05。另外,在治疗期间两组患者均未出现不良反应,或肾、肺、心等内脏功能衰退情况,药效较稳定温和。结论小儿感冒舒颗粒采用的是中成药制剂,较院内常规性治疗药物具有较为理想实际应用价值,其药理表现温和,药效较为稳定,治疗起效快,用药不良反应以及副作用小,可以作为临床常规性儿童急性上呼吸道感染用药。